Research on the development of Sylibum marianum hepatoprotective nanoparticles with high bioavailability

Programme 2007 - 2013 Hungary - Romania (HU-RO)

Date of latest update: 2021-04-06

Description

Description (EN):

The project aims to analyzing the therapeutic effects of the Sylibum marianum plant, also called milk thistle, to find new ways and medicine components for effectively treating liver diseases. Common food traditions (consumption of fats and spices, alcohol consumption) in the cross-border area (Hajdu-Bihar and Arad) have caused a 20% increase of liver diseases (hepatitis, cancer, cirrhosis) compared with other HU and RO counties. Medical statistics made in 2009 showed a EU average of 3.5% for hepatitis C, while in the border there was a doubling of incidence in the population (6%). Classical chemotherapy or other liver treatments (like interferon therapy in C and B hepatitis) are not always effective. Also, their application cause side effects and the total costs of treatment/patient is very high. For example, the annual cost of treatment/patient with hepatitis C is 20,000 euros and 15,000 euros for hepatitis B. In the border region, with a population of 1,000,000 inhabitants, the annual costs for hepatitis C is amounted to 1,200,000,000 euros. In this context, obtaining natural Nano products, as alternatives to classical therapy of liver diseases, with increased bioavailability, becomes a priority in biomedical research. But, to get finally competitive innovative Nano products on pharmaceutical market, is necessary to build up a powerful interdisciplinary research team, an effective partnership between the elite groups of scientists from different fields from border area: chemistry, biology, medicine, pharmacy, with experience in Nano products obtaining through Nano biotechnology and Nano medicine. General objective of the project is to strengthen cross-border co-operation in the field of applicative research of Nano biotechnology and Nano medicine domains. Specific objectives are the following: 1. Obtaining, characterization and encapsulation of Sylibum marianum active bio compounds in cyclodextrins 2. In vitro evaluation of hepatoprotective efficiency of nanoparticles (on hepatocytes cell lines). 3. In vivo evaluation of hepatoprotective efficiency of nanoparticles (on lab mice/rats). Target groups of the research are the project staff, experts, students, including PhD students involved directly in joint project implementation, academic staff (2000 persons), pharmaceutical companies from border area, gastroenterologists doctors and oncologists from cross-border region, patients with liver diseases from the area.

Website: http://www.huro-cbc.eu/

Thematic information

Health and social services Scientific cooperation

Partners (2)

Lead Partner: Debreceni Egyetem

Address: Nagyerdei út 98., 4032 Debrecen, Hungary

Legal status: n/a

Universitatea de Vest "Vasile Goldiş" Arad

Name: Universitatea de Vest "Vasile Goldiş" Arad

Address: B-ul Revolution no. 94–96., 310025 Arad, Romania

Legal status: n/a

Partners map

Partners and Projects info

Debreceni Egyetem

Research on the development of Sylibum marianum hepatoprotective nanoparticles with high bioavailability

Partners and Projects info

Universitatea de Vest "Vasile Goldiş" Arad

Research on the development of Sylibum marianum hepatoprotective nanoparticles with high bioavailability

Lead partner

Project partner

Summary

Project name (EN): Research on the development of Sylibum marianum hepatoprotective nanoparticles with high bioavailability

Project acronym: SM-NanoHepat

Project start date: 2010-09-01

Project end date: 2012-02-28

Project status: closed

Total budget/expenditure: EUR 383 215.00

Total EU funding (amount): EUR 322 614.95

Co-financing sources:

Information regarding the data in keep.eu on the programme financing this project

Financing programme

2007 - 2013 Hungary - Romania (HU-RO)

Last month that data in keep.eu was retrieved from the Programme's website or received from the Programme

2015-06-01

No. of projects in keep.eu / Total no. of projects (% of projects in keep.eu)

455 / 455 (100%)

No. of project partnerships in keep.eu / Total no. of project partnerships (% of project partnerships in keep.eu)

1 069 / 1 069 (100%)

Notes on the data

Information provided by the Programme and collected from programme's website

Languages

Contact Form

Research on the development of Sylibum marianum hepatoprotective nanoparticles with high bioavailability

Description

Thematic information

Partners (2)

Partners map

Summary

Information regarding the data in keep.eu on the programme financing this project

Disclaimer